Neomycin adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
The most common adverse reactions to oral neomycin are [[nausea]], [[vomiting]], and [[diarrhea]]. The "Malabsorption Syndrome" characterized by increased fecal fat, decreased serum carotene and fall in xylose absorption has been reported with prolonged therapy. [[Nephrotoxicity]], [[ototoxicity]], and neuromuscular blockage have been reported (see boxed WARNINGS and PRECAUTIONS section).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NEO-FRADIN (NEOMYCIN SULFATE) SOLUTION [X-GEN PHARMACEUTICALS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aea1d3e4-604a-4680-91e2-cce6a128a1b5 | publisher = | date = | accessdate = }}</ref> | The most common adverse reactions to oral neomycin are [[nausea]], [[vomiting]], and [[diarrhea]]. The "Malabsorption Syndrome" characterized by increased fecal fat, decreased serum [[carotene]] and fall in xylose absorption has been reported with prolonged therapy. [[Nephrotoxicity]], [[ototoxicity]], and neuromuscular blockage have been reported (see boxed WARNINGS and PRECAUTIONS section).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NEO-FRADIN (NEOMYCIN SULFATE) SOLUTION [X-GEN PHARMACEUTICALS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aea1d3e4-604a-4680-91e2-cce6a128a1b5 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 17:24, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Adverse Reactions
The most common adverse reactions to oral neomycin are nausea, vomiting, and diarrhea. The "Malabsorption Syndrome" characterized by increased fecal fat, decreased serum carotene and fall in xylose absorption has been reported with prolonged therapy. Nephrotoxicity, ototoxicity, and neuromuscular blockage have been reported (see boxed WARNINGS and PRECAUTIONS section).[1]
References
Adapted from the FDA Package Insert.